{2-(2-Methyl-2-propanyl)-6-[(E)-2-(1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)vinyl]-4H-pyran-4-ylidene}malononitrile(CAS: 200052-70-6)

The compound (2-(2-Methyl-2-propanyl)-6-[(E)-2-(1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)vinyl]-4H-pyran-4-ylidene}malononitrile) has a crystalline form. Its molecular weight is approximately 644.52 g/mol. It is slightly soluble in common organic solvents and shows moderate reactivity with nucleophiles. The compound is stable under normal conditions but may react with strong acids or bases.

The compound is typically synthesized by a series of reactions involving coupling of a malononitrile derivative with a pyridine-based compound. The reaction requires suitable catalysts and is performed under anhydrous conditions. The yield of the product is around 70-80%, with high selectivity towards the desired product.

This compound is primarily used in pharmaceuticals for its potential medicinal properties, such as anti-inflammatory and anti-oxidant activities. It has also shown interest in the development of new materials in the polymer and semiconductor industries.

When handling this compound, it is essential to use appropriate personal protective equipment (PPE), including gloves and goggles. Work should be conducted in a well-ventilated area or a fume hood. Spills should be contained and cleaned up using appropriate methods. Safety data sheets (SDS) should always be consulted for detailed handling and disposal information.